Icahn Says Future Is Big Pharma Will Buy Biotech (BIIB, AMLN)

June 4, 2009 1:39 PM EDT

Currently, my friend Mike Huckman is interviewing Carl Icahn over the phone on CNBC and asked him about what he plans to do with Biogen Idec (Nasdaq: BIIB) and Amylin (Nasdaq: AMLN). Icahn says he is not looking to sell Biogen Idec and Amylin Pharmaceuticals anytime soon. First, management needs to streamline things and get both of their operations in order.

Create E-mail AlertRelated Categories

Insiders' Blog
Rumors

Stocks Mentioned

Related Entities

• Carl Icahn

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?